Synthetic pharmaceutical was listed as one of China's top 10 pharmaceutical innovation capabilities in 2015

In 2015, the tragic and joyful two days, the crash trilogy (crash · Pharmaceutical companies tidal withdrawal varieties (third part)) mentioned that 1622 self-examination varieties have been killed in more than half, pharmaceutical companies please don't cry, the other side of the withdrawal is the bright sun, clinical approval documents flooded to pharmaceutical companies.
      According to the latitude statistics of the review conclusions, a total of 3,779 clinical approvals rushed to pharmaceutical companies in 2015. Chemical drugs are still absolutely dominant (2852), a total of 23 clinical approvals of traditional Chinese medicine, 19 of which are 6.1 new drugs, the development of traditional Chinese medicine is really not easy, calling for the simplification of the approval policy of compound preparations derived from ancient classic prescriptions.
      In 2015, there are a total of 6906 acceptance numbers (approved + not approved), and many acceptance numbers are gradually withdrawn, to know that the annual average acceptance of CDE in 2013-2015 is about 8000, folks, so full power, the future may no longer have to worry about queuing.